Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants - Top-Institutions - MDSpire

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

  • By

  • Nicholas A. Marston

  • Shinwan Kany

  • Giorgio E. M. Melloni

  • Sean J. Jurgens

  • Frederick K. Kamanu

  • Yi-Pin Lai

  • Joel T. Rämö

  • Itamar Raz

  • Stephen D. Wiviott

  • Patrick T. Ellinor

  • Marc S. Sabatine

  • Christian T. Ruff

  • June 8, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology
    • Genetics

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology
    • Genetics

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Cardiology

  • #4

    University of Leipzig
    University of Leipzig

    Leipzig, Germany

    Key Differentiators

    • Cardiology

  • #5

    Montefiore Medical Center
    Montefiore Medical Center

    Bronx, New York

    Key Differentiators

    • Cardiology

Original Source(s)

Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

  • by Nicholas A. Marston, Shinwan Kany, Giorgio E. M. Melloni, Sean J. Jurgens, Frederick K. Kamanu, Yi-Pin Lai, Joel T. Rämö, Itamar Raz, Stephen D. Wiviott, Patrick T. Ellinor, Marc S. Sabatine, Christian T. Ruff

  • June 8, 2026

Related Content

Exercise modalities and dose-response for LVEF Improvement in heart failure patients: a systematic review and network meta-analysis

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.